GeraClinic / NHS cancer waiting times / NHS Central East ICB / Urgent Suspected Cancer (2-Week Wait)
NHS Central East ICB: Urgent Suspected Cancer (2-Week Wait) — 62-Day Cancer Waits
In April 2026, 67.4% of urgent suspected cancer (2-week wait) cancer patients in NHS Central East ICB started treatment within 62 days — 748 patients on this pathway. NHS target: 85%. Official NHS England data.
What is the Urgent Suspected Cancer (2-Week Wait) cancer waiting time in NHS Central East ICB?
As of April 2026, 67.4% of urgent suspected cancer (2-week wait) cancer patients in NHS Central East ICB started treatment within 62 days of referral (504 of 748 patients, NHS target: 85%), per NHS England Cancer Waiting Times data published June 2026. Gera re-dates this monthly.
| Measure | Value | Context |
|---|---|---|
| Patients on pathway | 748 | April 2026 |
| Within 62 days | 504 | Started treatment in time |
| Breaches | 244 | Did not meet 62-day standard |
| 62-day standard met | 67.4% | NHS target: 85% |
| Status vs target | MISSED | Target is 85% |
Other cancer pathways in NHS Central East ICB
NHS Central East ICB USC 2WW cancer waits: FAQs
- What is the 62-day cancer waiting time for Urgent Suspected Cancer (2-Week Wait) in NHS Central East ICB?
- In April 2026, 67.4% of urgent suspected cancer (2-week wait) cancer patients in NHS Central East ICB started treatment within 62 days of referral — covering 748 patients (504 within standard, 244 breaches). NHS target: 85%. Data: NHS England Cancer Waiting Times, June 2026.
- What does the Urgent Suspected Cancer (2-Week Wait) pathway mean?
- The Urgent Suspected Cancer (2-Week Wait) pathway covers patients referred urgently by their GP with symptoms suggesting cancer. They should be seen by a specialist within 14 days (2-week wait) and, if diagnosed, start treatment within 62 days of referral. This is the highest-volume cancer pathway.
- How does NHS Central East ICB's USC 2WW performance compare to England?
- The England average for the 62-day Urgent Suspected Cancer (2-Week Wait) pathway was not separately published at England level in the April 2026 extract. NHS Central East ICB's 67.4% performance can be compared against the overall England 62-day combined standard met rate and the NHS 85% target.
- What counts as a breach of the 62-day cancer standard?
- A breach occurs when a patient does not start their first definitive cancer treatment within 62 days of the relevant referral date (2-week wait, upgrade, screening referral, or breast symptomatic). In NHS Central East ICB for the Urgent Suspected Cancer (2-Week Wait) pathway in April 2026, there were 244 breaches out of 748 patients.
USC 2WW cancer waits in NHS Central East ICB — below NHS target
Only 67.4% of urgent suspected cancer (2-week wait) patients in NHS Central East ICB met the 62-day standard in April 2026 (target: 85%). GeraClinic can connect you to a UK-registered cancer specialist while you await NHS assessment — your referral is not affected.
Contains public sector information published by NHS England and licensed under the Open Government Licence v3.0. Data: Cancer Waiting Times CRS Database, April 2026. Methodology.